On December 15, TheFly published that Luke Sergott, a Barclays analyst, lifted the price objective for Pacific Biosciences of ...

The roller-coaster ride for Regencell Bioscience Holdings shares continued in today's session. The stock price quadrupled when a 38-to-1 stock split went into effect last month, and it skyrocketed 122 ...

Get the latest analysis on Regencell Bioscience (RGC): liquidity risks, DOJ investigation, and lack of revenue.

What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 6.1% in the afternoon ...

D. Boral Capital upgraded Artelo Biosciences, Inc. (NASDAQ:ARTL) on Tuesday. The analyst upgraded from Hold to Buy and introduced a price forecast of $20. Analyst Jason Kolbert wrote, “We continue to ...

It is being acquired for quite a meaty premium. The buyer is a top name in the global pharmaceuticals space. The purchasing party is global pharmaceutical company Novartis, which on Sunday divulged ...

Vyne Therapeutics is set to combine with Yarrow Bioscience in an all-stock merger. Vyne, a clinical-stage biopharmaceutical company, and Yarrow Bioscience, a clinical-stage biotechnology company said ...

Skye Bioscience, Inc. announced that it has granted stock options for 56,000 shares of its common stock to two new non-executive employees as part of its 2024 Inducement Equity Incentive Plan, in ...